The global home diagnostics market size was USD 6.23 billion in 2023, calculated at USD 6.56 billion in 2024 and is expected to reach around USD 11 billion by 2034, expanding at a CAGR of 5.3% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Home Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Home Diagnostics Market, by Test Type, 2024-2034
8.1.1. Glucose Monitoring Devices
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Pregnancy Test
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Ovulation Predictor Test Kits
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. HIV Test Kits
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Cholesterol Detection Kits
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Infection Testing Kits
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Drug of Abuse Test Kits
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2034)
9.1. Home Diagnostics Market, by Form, 2024-2034
9.1.1. Cassettes
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Midstream
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Instruments
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Strips
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Test
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Digital Monitoring
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Dip Cards
9.1.7.1. Market Revenue and Forecast (2021-2034)
10.1. Home Diagnostics Market, by Distribution Channel, 2024-2034
10.1.1. Retail Pharmacies
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Drug Stores
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Hypermarket & Supermarkets
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Online Pharmacies
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Test (2021-2034)
11.1.2. Market Revenue and Forecast, by Form (2021-2034)
11.1.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Form (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Form (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test (2021-2034)
11.2.2. Market Revenue and Forecast, by Form (2021-2034)
11.2.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Form (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Form (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Form (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Form (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test (2021-2034)
11.3.2. Market Revenue and Forecast, by Form (2021-2034)
11.3.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Form (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Form (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Form (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Form (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test (2021-2034)
11.4.2. Market Revenue and Forecast, by Form (2021-2034)
11.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Form (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Form (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Form (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Form (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test (2021-2034)
11.5.2. Market Revenue and Forecast, by Form (2021-2034)
11.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Form (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Form (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BTNX, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Becton Dickinson & Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. ACON Laboratories, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. ARKRAY Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Roche Holding AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Assure Tech
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. SA Scientific
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Zeotis Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Bionime Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Quidel Corporation
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample